Aurintricarboxylic acid induces a distinct activation of the igf-i receptor signaling within mda-231 cells

Endocrinology

Volumn 143, Issue 3, 2002, Pages 837-845

  Haimsohn, Michal ^a   Beery, Rachel ^b   Karasik, Avraham ^a   Kanety, Hannah ^a   Geier, Avraham ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; APOPTOSIS INHIBITOR; AURINTRICARBOXYLIC ACID; CYCLOHEXIMIDE; DOXORUBICIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; ISOENZYME; ISOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN SHC; PROTEIN SYNTHESIS INHIBITOR; RECEPTOR ANTIBODY; RECEPTOR SUBUNIT; RICIN; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; DEPHOSPHORYLATION; DISULFIDE BOND; DRUG EXPOSURE; DRUG MECHANISM; DRUG POTENCY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; PROTEIN TERTIARY STRUCTURE; SIGNAL TRANSDUCTION;

EID: 0036171227     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.143.3.8681     Document Type: Article

References (34)

1. r 6,400 aurintricarboxlic acid directly activates platelets
2. Aurintricarboxylic acid is a nonspecific enzyme inhibitor
3. Use of aurintricarboxylic acid as an inhibitor of nucleases during nucleic acid isolation
4. Calcium-activated DNA fragmentation kills immature thymocytes
5. Aurintricarboxylic acid rescues PC12 cells and sympathetic neurons from cell death caused by nerve growth factor deprivation: Correlation with suppression of endonuclease activity
6. Aurintricarboxylic acid prevents NMDA-mediated excitotoxicity: Evidence for its action as an NMDA receptor antagonist
7. Aurintricarboxylic acid protects hippocampal neurons from NMDA- and ischemia-induced toxicity in vivo
8. Role of DNA fragmentation in T cell activation-induced apoptosis in vitro and in vivo
9. Multiple pathways are involved in protection of MCF-7 cells against death due to protein synthesis inhibition
10. Aurintricarboxylic acid promotes survival and regeneration of axotomised retinal ganglion cells in vivo
11. Aurintricarboxylic acid a non-antibiotic organic molecule that inhibits protein synthesis
12. Ordering the cell death pathway
13. Activation of the Jak2-Stat5 signaling pathway in Nb2 lymphoma cells by an anti-apoptotic agent, aurintricarboxylic acid
14. A neuroprotective compound, aurintricarboxylic acid, stimulates the tyrosine phosphorylation cascade in PC12 cells
15. Activation of insulin-like growth factor 1 signaling pathway by the anti-apoptotic agents aurintricarboxylic acid and Evans blue
16. Induction of apoptosis in MDA-231 cells by protein synthesis inhibitors is suppressed by multiple agents
17. Epidermal growth factor, phorbol esters and aurintricarboxylic acid are survival factors for MDA-231 cells exposed to adriamycin
18. Growth inhibition of MCF-7 breast cancer cells by stable expression of an insulin-like growth factor I receptor antisense ribonucleic acid
19. Altered expression of the IGF-1 receptor in a tamoxifen-resistant human breast cancer cell line
20. Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis
21. The effects of insulin-like growth factor-I (IGF-I), IGF-II and des-(1-3)IGF-I, a potent IGF analogue, on growth hormone and IGF-binding protein secretion from cultured rat interior pituitary cells
22. Type 1 IGF receptor in human breast diseases
23. Expression of the insulin-like growth factor 1 receptor (IGF-1R) in breast cancer cells: Evidence for a regulatory role of dolichyl phosphate in the transition from an intracellular to an extracellular IGF-1 pathway
24. Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways
25. Multiple signaling pathways of the insulin-like growth factor-receptor in protection of apoptosis
26. The role of the insulin-like growth factors in cancer
27. Domains of the insulin-like growth factor I receptor required for the activation of extracellular signal-regulated kinases
28. Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor-I, insulin, and interleukin-4 in estrogen receptor-positive human breast cancer cells
29. Antiapoptotic signaling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt
30. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
31. Evidence for a differential interaction of SHC and the insulin receptor substrate-1 (IRS-1) with the insulin-like growth factor-I (IGF-I) receptor in the yeast two-hybrid system
32. Proteolytic processing of the insulin receptor β-subunit is associated with insulin-induced receptor down-regulation
33. Insulin resistance is mediated by a proteolytic fragment of the insulin receptor
34. Subunit structure of the purified human placental insulin receptor